Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Safety and Efficacy of Avanafil in Erectile Dysfunction
NCT00853606Phase 3Completed
- Sponsor
- VIVUS
- Start
- Mar 2009
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of avanafil in erectile dysfunction (ED), sponsored by VIVUS. Primary endpoints: Percentage of Sexual Attempts with Successful Intercourse at 52 weeks, Percentage of Sexual Attempts with Successful Penetration at 52 weeks and 1 more. Started Mar 2009; status: completed.
02
Drugs
avanafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT00853606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00853606.